EMA Guidance on Trial Mgmt during COVID-19
Health Care, Pharma Industry, Strategic Planning
The impact of COVID-19 on ongoing trials, on opening a new trial site in an existing trial, ongoing recruitment and continued involvement of participants in the trial, or on starting of new trials needs to be considered. Read this EMA Guidance to learn more about managing your clinical trials during this pandemic.
Related Education Resources.
All ResourcesEAP video blog
Topics: Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning
Video
Members
Preparing for the Post-Brexit Clinical Supply Chain
Topics: Pharma Industry, Regulatory
Position Paper
Free
Demand Forecasting and the Management of IRT
Topic: Technology
Webinar
Free
